journal
https://read.qxmd.com/read/36961762/severe-hyponatremia-manifesting-as-status-epilepticus-caused-by-a-single-dose-of-cyclophosphamide
#1
JOURNAL ARTICLE
Abdelrahman Nanah, Seema Misbah, Hamed Daw
No abstract text is available yet for this article.
March 24, 2023: American Journal of Therapeutics
https://read.qxmd.com/read/36881440/rituximab-for-covid-19-vaccine-associated-pemphigus-vulgaris
#2
JOURNAL ARTICLE
Hai-Zhen Hui, Ying-Jun Wang, Jia-Rong Cheng, Han Mao, Hong-Xing Guo, Qing-Chun Diao, Bing-Jun Shi
No abstract text is available yet for this article.
March 7, 2023: American Journal of Therapeutics
https://read.qxmd.com/read/36867515/a-comparison-of-variable-versus-fixed-insulin-infusion-rate-on-resolution-of-diabetic-ketoacidosis
#3
JOURNAL ARTICLE
Nathan Bohach, John M Moorman, Brittany Cunningham, Chanda Mullen, Melissa Fowler
BACKGROUND: Diabetic ketoacidosis (DKA) is a well-known, potentially fatal complication of diabetes. The American Diabetes Association hyperglycemic crises guidelines suggest the use of intravenous insulin in patients presenting with DKA, along with a recommended rate of glucose reduction of 50-75 mg/dL/h. However, no specific guidance is provided regarding how to best achieve this rate of glucose decline. STUDY QUESTION: Is there a difference in time to DKA resolution between a variable intravenous insulin infusion strategy and a fixed infusion strategy in the absence of an institutional protocol? STUDY DESIGN: Single-center, retrospective cohort study of DKA patient encounters in 2018...
March 3, 2023: American Journal of Therapeutics
https://read.qxmd.com/read/36856587/improvement-of-refractory-chronic-actinic-dermatitis-during-tofacitinib-treatment
#4
JOURNAL ARTICLE
Ying-Jun Wang, Hai-Zhen Hui, Jia-Rong Cheng, Han Mao, Qing-Chun Diao, Bing-Jun Shi
No abstract text is available yet for this article.
March 1, 2023: American Journal of Therapeutics
https://read.qxmd.com/read/36856572/antidepressants-are-associated-with-a-reduction-in-the-risk-of-death-in-covid-19-disease-patients
#5
JOURNAL ARTICLE
Raquel Cobos-Campos, Arantza Sáez de Lafuente-Moríñigo, José Aurelio Cordero-Guevara, Cristina Bermúdez-Ampudia, Antxon Apiñaniz, Julene Argaluza, Naiara Parraza
No abstract text is available yet for this article.
February 28, 2023: American Journal of Therapeutics
https://read.qxmd.com/read/36856570/analytic-cannabis-effect-on-hepatic-steatosis-and-hepatic-fibrosis-a-meta-analytic-evaluation
#6
JOURNAL ARTICLE
Manesh Kumar Gangwani, Mohamad Nawras, Fnu Priyanka, Muhammad Aziz, Asif Mahmood
No abstract text is available yet for this article.
February 28, 2023: American Journal of Therapeutics
https://read.qxmd.com/read/36848632/levofloxacin-associated-encephalopathy
#7
JOURNAL ARTICLE
Ayako Kumabe, Tsuneaki Kenzaka
No abstract text is available yet for this article.
February 27, 2023: American Journal of Therapeutics
https://read.qxmd.com/read/36811898/anakinra-an-interleukin-1-receptor-antagonist-for-covid-19
#8
JOURNAL ARTICLE
Timothy Nguyen, Lorena Dima, Kristine C Willett
BACKGROUND: Coronavirus disease (COVID-19) caused by SARS-CoV-2 virus caused a global pandemic in 2019. There are limited pharmacologic options available. The Food and Drug Administration initiated an emergency use authorization process to expedite pharmacologic agents to treat COVID-19. There are several agents available through the emergency use authorization process, ritonavir-boosted nirmatrelvir, remdesivir, and baricitinib. Anakinra is an interleukin (IL)-1 receptor antagonist that exhibits properties in fighting against COVID-19...
February 22, 2023: American Journal of Therapeutics
https://read.qxmd.com/read/36811867/the-challenge-of-intermediate-risk-pulmonary-embolism
#9
JOURNAL ARTICLE
Spencer F Weintraub, Joseph You, Sean Wilson, Andrew Galmer
BACKGROUND: Intermediate-risk pulmonary embolism is a common disease that is associated with significant morbidity and mortality; however, a standardized treatment protocol is not well-established. AREAS OF UNCERTAINTY: Treatments available for intermediate-risk pulmonary embolisms include anticoagulation, systemic thrombolytics, catheter-directed therapies, surgical embolectomy, and extracorporeal membrane oxygenation. Despite these options, there is no clear consensus on the optimal indication and timing of these interventions...
February 22, 2023: American Journal of Therapeutics
https://read.qxmd.com/read/36811851/oral-chemotherapeutic-ingestions-reported-to-a-poison-control-center-treated-in-a-health-care-facility
#10
JOURNAL ARTICLE
Sam Ontiveros, Brenna Hogue, Allyson Kreshak, Christopher Coyne, Lee Cantrell, Alicia Minns
BACKGROUND: The approach to cancer chemotherapy has changed in recent years, and there are several new oral chemotherapeutics that offer convenience to patients. These medications have toxicity, which may be particularly amplified in an overdose. STUDY DESIGN: This was a retrospective review of all oral chemotherapy overdoses reported to the California Poison Control System between January 2009 and December 2019. Inclusion criteria were all ingestions coded as "antineoplastic, monoclonal antibody, or thalidomide" that were evaluated at a health care facility...
February 22, 2023: American Journal of Therapeutics
https://read.qxmd.com/read/36806553/massive-ethylene-glycol-self-administration-with-acute-kidney-injury-treated-with-fomepizole-alone
#11
JOURNAL ARTICLE
Duc M Dang, Michelle A Hieger
No abstract text is available yet for this article.
February 20, 2023: American Journal of Therapeutics
https://read.qxmd.com/read/36799867/abrocitinib-for-the-treatment-of-moderate-to-severe-atopic-dermatitis
#12
JOURNAL ARTICLE
Susan C Villegas, Lorena Dima
BACKGROUND: Atopic dermatitis (AD) is ranked as the third most prevalent skin condition with a worldwide prevalence of 2.4%. Atopic dermatitis is a common form of eczema. It develops in infancy or childhood and continues into adulthood with symptoms ranging from mild to severe. Pruritis and inflammation are the hallmark symptoms of AD. MECHANISM OF ACTION, PHARMACODYNAMICS, AND PHARMACOKINETICS: Abrocitinib is a JAK1 selective inhibitor; inhibition results in a decreased interleukin (IL) 4 activation and decreased pruritis in a patient with AD...
February 17, 2023: American Journal of Therapeutics
https://read.qxmd.com/read/36762927/ivermectin-and-the-emergence-of-long-covid
#13
JOURNAL ARTICLE
Peter Manu
No abstract text is available yet for this article.
February 10, 2023: American Journal of Therapeutics
https://read.qxmd.com/read/36762925/advances-in-genetic-editing-of-the-human-embryo
#14
JOURNAL ARTICLE
Vasile Astarăstoae, Beatrice Gabriela Ioan, Liliana M Rogozea, Bianca Hanganu
BACKGROUND: Genetic engineering has allowed a major development of research in this field, with specialists attempting to edit the human genome, after the successful editing of the genomes of plants and animals. However, human gene editing technologies are at the center of ethical debates around the world. AREAS OF UNCERTAINTY: Ethical concerns about genetic editing of the human embryo raise several issues that can be viewed through the prism of optimism and reluctance leading to a number of recommendations regarding the acceptance of what may soon become a reality...
February 10, 2023: American Journal of Therapeutics
https://read.qxmd.com/read/36637447/testing-for-glucose-6-phosphate-dehydrogenase-deficiency-before-rasburicase-use-for-tumor-lysis-syndrome
#15
JOURNAL ARTICLE
Rachaita Lakra, Udhayvir Singh Grewal, Poornima Ramadas
No abstract text is available yet for this article.
January 12, 2023: American Journal of Therapeutics
https://read.qxmd.com/read/36728323/amiodarone-rechallenge-associated-myoclonus
#16
JOURNAL ARTICLE
Shweta Paulraj, Jamal Ahmed
No abstract text is available yet for this article.
January 9, 2023: American Journal of Therapeutics
https://read.qxmd.com/read/36728521/statin-use-and-delirium-risk-an-updated-systematic-review-and-meta-analysis
#17
JOURNAL ARTICLE
Ya-Hui Chang, Jian-Ying Wang, Tzu-Rong Peng, Jia-Haur Lian, Ming-Chia Lee, Hui-Ming Chen
BACKGROUND: Findings on the association of statin use with delirium risk are inconsistent. THE STUDY QUESTION: Is statin use associated with delirium risk? STUDY DESIGN: We searched PubMed, the Cochrane Library, and the EMBASE database, limiting the search to human patients and articles in English published until December 31, 2021. The effect size and 95% confidence interval (CI) were defined as the odds ratio (OR) and 95% CI, respectively, to indicate the difference in the incidence of delirium between statin use and nonuse groups...
January 2, 2023: American Journal of Therapeutics
https://read.qxmd.com/read/36728507/defibrillator-lead-retention-and-suppressive-antibiotic-treatment-for-gram-negative-bacterial-endocarditis
#18
JOURNAL ARTICLE
Alexandros Briasoulis, Kiki Kontitsi, Ioanna Rentziou
No abstract text is available yet for this article.
January 2, 2023: American Journal of Therapeutics
https://read.qxmd.com/read/36607228/attention-deficit-hyperactivity-disorder-associated-impulsive-aggression-psychopharmacological-considerations
#19
JOURNAL ARTICLE
Ahmed Naguy, Bibi Alamiri
No abstract text is available yet for this article.
January 2, 2023: American Journal of Therapeutics
https://read.qxmd.com/read/36892562/dasatinib-associated-spontaneous-gluteal-hematoma-and-hemorrhagic-shock
#20
LETTER
Daniel Park, Chloie Limpin Flores, Muhammad Firdaus, Waqas Aslam
No abstract text is available yet for this article.
March 2023: American Journal of Therapeutics
journal
journal
32115
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.